Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faiez Zannad

Showing results (1-10 of 1,137) with videos related to

Pageof 114
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Pharmacotherapy in heart failure with reduced ejection fraction during the last 20 years, and the way ahead for precision medicineFaiez Zannad
European Heart Journal. Cardiovascular Pharmacotherapy|May 26, 2017
Response to comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et alFaiez Zannad
Journal of the American College of Cardiology|October 15, 2025
The Adipokine Hypothesis of HFpEF: A Bold Unifying Framework in Need of Translational ProofFaiez Zannad
Lancet (London, England)|November 28, 2017
Rising incidence of heart failure demands actionFaiez Zannad
Circulation. Heart Failure|March 20, 2014
What is measured by cardiac fibrosis biomarkers and imaging?Faiez Zannad
La Tunisie Medicale|September 26, 2022
A winner is a loser who tried once moreFaiez Zannad
Journal of the American College of Cardiology|October 27, 2022
Heart Failure and Kidney Disease in Type 2 Diabetes: 2 Sides of the Same CoinFaiez Zannad
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 22, 2022
Neuromodulation in heart failure<sup></sup>Faiez Zannad
Journal of Hypertension|March 14, 2007
Aldosterone antagonist therapy in resistant hypertensionFaiez Zannad
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 15, 2009
Implications of the ADVANCE study for clinical practiceFaiez Zannad
Pageof 114

Showing results (1-10 of 1,137) with videos related to

Sort By:
Pageof 114
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Pharmacotherapy in heart failure with reduced ejection fraction during the last 20 years, and the way ahead for precision medicineFaiez Zannad
European Heart Journal. Cardiovascular Pharmacotherapy|May 26, 2017
Response to comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et alFaiez Zannad
Journal of the American College of Cardiology|October 15, 2025
The Adipokine Hypothesis of HFpEF: A Bold Unifying Framework in Need of Translational ProofFaiez Zannad
Lancet (London, England)|November 28, 2017
Rising incidence of heart failure demands actionFaiez Zannad
Circulation. Heart Failure|March 20, 2014
What is measured by cardiac fibrosis biomarkers and imaging?Faiez Zannad
La Tunisie Medicale|September 26, 2022
A winner is a loser who tried once moreFaiez Zannad
Journal of the American College of Cardiology|October 27, 2022
Heart Failure and Kidney Disease in Type 2 Diabetes: 2 Sides of the Same CoinFaiez Zannad
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 22, 2022
Neuromodulation in heart failure<sup></sup>Faiez Zannad
Journal of Hypertension|March 14, 2007
Aldosterone antagonist therapy in resistant hypertensionFaiez Zannad
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 15, 2009
Implications of the ADVANCE study for clinical practiceFaiez Zannad
Pageof 114